Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 32 entries
Sorted by: Best Match Show Resources per page
Identification of genomic features in the classification of loss- and gain-of-function mutation.

BMC medical informatics and decision making

Jung S, Lee S, Kim S, Nam H.
PMID: 26043747
BMC Med Inform Decis Mak. 2015;15:S6. doi: 10.1186/1472-6947-15-S1-S6. Epub 2015 May 20.

BACKGROUND: Alterations of a genome can lead to changes in protein functions. Through these genetic mutations, a protein can lose its native function (loss-of-function, LoF), or it can confer a new function (gain-of-function, GoF). However, when a mutation occurs,...

Phenotypic spectrum of POLG1 mutations.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Finsterer J, Scorza FA.
PMID: 28905223
Neurol Sci. 2018 Mar;39(3):571-573. doi: 10.1007/s10072-017-3116-1. Epub 2017 Sep 13.

No abstract available.

The preclinical stage of spinocerebellar ataxias.

Neurology

Maas RP, van Gaalen J, Klockgether T, van de Warrenburg BP.
PMID: 26062625
Neurology. 2015 Jul 07;85(1):96-103. doi: 10.1212/WNL.0000000000001711. Epub 2015 Jun 10.

The autosomal dominant spinocerebellar ataxias (SCAs) are a heterogeneous group of degenerative diseases of the cerebellum and connected regions. The discovery of various SCA genes and the subsequent possibility of predictive testing currently allow a genetic diagnosis to be...

Congenital myasthenic syndromes: gene mutations.

Neuromuscular disorders : NMD

Ohno K, Engel AG.
PMID: 14702950
Neuromuscul Disord. 2004 Jan;14(1):117-22. doi: 10.1016/s0960-8966(03)00241-4.

No abstract available.

Microarray analysis: the evolving story of oral polio vaccines.

Heredity

Breuer J.
PMID: 14603348
Heredity (Edinb). 2004 Jan;92(1):3-4. doi: 10.1038/sj.hdy.6800373.

No abstract available.

The expanding universe of inflammatory bowel disease genetics.

Current opinion in gastroenterology

Achkar JP, Duerr R.
PMID: 18622155
Curr Opin Gastroenterol. 2008 Jul;24(4):429-34. doi: 10.1097/MOG.0b013e3283009c92.

PURPOSE OF REVIEW: Genetic factors play an important role in the pathogenesis of inflammatory bowel disease. In this review, we will provide an update on the rapid advances in the discovery of inflammatory bowel disease, primarily Crohn's disease, associated...

Data mining using the Catalogue of Somatic Mutations in Cancer BioMart.

Database : the journal of biological databases and curation

Shepherd R, Forbes SA, Beare D, Bamford S, Cole CG, Ward S, Bindal N, Gunasekaran P, Jia M, Kok CY, Leung K, Menzies A, Butler AP, Teague JW, Campbell PJ, Stratton MR, Futreal PA.
PMID: 21609966
Database (Oxford). 2011 May 23;2011:bar018. doi: 10.1093/database/bar018. Print 2011.

Catalogue of Somatic Mutations in Cancer (COSMIC) (http://www.sanger.ac.uk/cosmic) is a publicly available resource providing information on somatic mutations implicated in human cancer. Release v51 (January 2011) includes data from just over 19,000 genes, 161,787 coding mutations and 5573 gene...

De novo mutation in schizophrenia.

Schizophrenia bulletin

Rees E, Kirov G, O'Donovan MC, Owen MJ.
PMID: 22451492
Schizophr Bull. 2012 May;38(3):377-81. doi: 10.1093/schbul/sbs047. Epub 2012 Mar 26.

Several studies in the last 5 years have shown that newly arising (de novo) mutations contribute to the genetics of schizophrenia (SZ). This will replenish genetic variants removed by natural selection and could, in part, explain why SZ prevalence...

Using MEMo to discover mutual exclusivity modules in cancer.

Current protocols in bioinformatics

Ciriello G, Cerami E, Aksoy BA, Sander C, Schultz N.
PMID: 23504936
Curr Protoc Bioinformatics. 2013 Mar;Unit 8.17. doi: 10.1002/0471250953.bi0817s41.

Although individual tumors show surprisingly diverse genomic alterations, these events tend to occur in a limited number of pathways, and alterations that affect the same pathway tend to not co-occur in the same patient. While pathway analysis has been...

Integrative Analyses of De Novo Mutations Provide Deeper Biological Insights into Autism Spectrum Disorder.

Cell reports

Takata A, Miyake N, Tsurusaki Y, Fukai R, Miyatake S, Koshimizu E, Kushima I, Okada T, Morikawa M, Uno Y, Ishizuka K, Nakamura K, Tsujii M, Yoshikawa T, Toyota T, Okamoto N, Hiraki Y, Hashimoto R, Yasuda Y, Saitoh S, Ohashi K, Sakai Y, Ohga S, Hara T, Kato M, Nakamura K, Ito A, Seiwa C, Shirahata E, Osaka H, Matsumoto A, Takeshita S, Tohyama J, Saikusa T, Matsuishi T, Nakamura T, Tsuboi T, Kato T, Suzuki T, Saitsu H, Nakashima M, Mizuguchi T, Tanaka F, Mori N, Ozaki N, Matsumoto N.
PMID: 29346770
Cell Rep. 2018 Jan 16;22(3):734-747. doi: 10.1016/j.celrep.2017.12.074.

Recent studies have established important roles of de novo mutations (DNMs) in autism spectrum disorders (ASDs). Here, we analyze DNMs in 262 ASD probands of Japanese origin and confirm the "de novo paradigm" of ASDs across ethnicities. Based on...

Genetic architecture of autism spectrum disorder: Lessons from large-scale genomic studies.

Neuroscience and biobehavioral reviews

Choi L, An JY.
PMID: 34166716
Neurosci Biobehav Rev. 2021 Sep;128:244-257. doi: 10.1016/j.neubiorev.2021.06.028. Epub 2021 Jun 21.

Autism spectrum disorder (ASD) is a neurodevelopmental disorder with a strong genetic component. Recently developed genomic technologies, including microarray and next-generation sequencing (NGS), have enabled researchers to genetic analyses aimed at identifying genetic variations associated with ASD and to...

Overview of the BioCreative VI Precision Medicine Track: mining protein interactions and mutations for precision medicine.

Database : the journal of biological databases and curation

Islamaj Dogan R, Kim S, Chatr-Aryamontri A, Wei CH, Comeau DC, Antunes R, Matos S, Chen Q, Elangovan A, Panyam NC, Verspoor K, Liu H, Wang Y, Liu Z, Altinel B, Hüsünbeyi ZM, Özgür A, Fergadis A, Wang CK, Dai HJ, Tran T, Kavuluru R, Luo L, Steppi A, Zhang J, Qu J, Lu Z.
PMID: 30689846
Database (Oxford). 2019 Jan 01;2019. doi: 10.1093/database/bay147.

The Precision Medicine Initiative is a multicenter effort aiming at formulating personalized treatments leveraging on individual patient data (clinical, genome sequence and functional genomic data) together with the information in large knowledge bases (KBs) that integrate genome annotation, disease...

Showing 1 to 12 of 32 entries